Amyris, Inc. (NASDAQ:AMRS) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07
As previously reported in the Prior 8-K, which is incorporated herein by reference, at the Company’s 2017 Annual Meeting of Stockholders held on May23, 2017, the Company’s stockholders voted to approve conducting future stockholder say-on-pay votesonce every three years. In light of such vote, which was consistent with the recommendation of the Company’s Board of Directors (the “Board”), on August 2, 2017, the Company, with the support of the Board, decided to conduct future stockholder say-on-pay votes once every three years until the next required vote on the frequency of future stockholder say-on-pay votes, although an earlier vote on such frequency may be held at the Board’s discretion.
About Amyris, Inc. (NASDAQ:AMRS)
Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.